MetaCap

Actinium Pharmaceuticals (Delaware) (ATNM) vs Veru (VERU)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Veru (VERU) has outperformed Actinium Pharmaceuticals (Delaware) (ATNM) over the past year, losing 12.6% versus a loss of 21.1%. Over five years, ATNM leads with a -85.6% price change compared with -97.5% for VERU. Veru is the larger company by market cap ($33.1 million vs $33.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ATNM-21.05%VERU-12.61%
+97%+23%-50%
Nov 21, 20251 yearNov 20, 2026
ATNM-86.22%VERU-97.52%
+156%+23%-110%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ATNM versus VERU key metrics
MetricATNMVERU
Share price$1.05$1.94
Market cap$33.01M$33.08M
1-day change-1.87%-8.06%
YTD return-22.79%-9.35%
1-year return-21.05%-12.61%
5-year return-85.60%-97.50%
P/E ratio (TTM)2.44—
EPS (TTM)$0.43$-0.61
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$90.00K—
Net income (latest FY)$-33.89M$-22.73M
Operating margin-40274.44%—
Net margin-37652.22%—
52-week high$1.72$7.33
52-week low$0.735$1.93
Distance from 52-week high-38.95%-73.53%
Analyst consensusnonestrong_buy
Avg. price target upside+242.86%+1223.20%
Average volume193.83K193.35K
Shares outstanding31.44M17.05M
Employees2720
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Actinium Pharmaceuticals (Delaware)

ATNM stock →

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Health Care · Biotechnology: Pharmaceutical Preparations · 27 employees

About Veru

VERU stock →

Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.

Health Care · Biotechnology: Pharmaceutical Preparations · 20 employees

ATNM vs VERU FAQ

Which is bigger, Actinium Pharmaceuticals (Delaware) or Veru?

Veru (VERU) is larger, with a market capitalization of $33.08M compared with $33.01M for Actinium Pharmaceuticals (Delaware) (ATNM).

Which stock has performed better over the past year, ATNM or VERU?

VERU returned -12.61% over the past 12 months, compared with -21.05% for ATNM (price return, excluding dividends). Past performance does not predict future results.

Are Actinium Pharmaceuticals (Delaware) and Veru in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons